| Identification | |
| Name: | Voriconazole |
| Synonyms: | 4-Pyrimidineethanol, alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-,(alphaR,betaS)-;DRG-0301;UK-109,496;UNII-JFU09I87TR;Vfend;VRC; |
| CAS: | 137234-62-9 |
| Molecular Formula: | C16H14F3N5O |
| Molecular Weight: | 349.31047 [g/mol] . |
| InChI: | InChI=1S/C16H14F3N5O/c1-10(15-14(19)5-20-7-22-15)16(25,6-24-9-21-8-23-24)12-3-2-11(17)4-13(12)18/h2-5,7-10,25H,6H2,1H3/t10-,16+/m0/s1 |
| Molecular Structure: |  |
| Properties | |
| Transport: | OTH |
| Density: | 1.42 g/cm3 |
| Appearance: | white to off white crystalline powder |
| Specification: |
?Voriconazole , its cas register number is 137234-62-9. It also can be called?Voriconazole [USAN:INN:BAN] ; (alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol ; 4-Pyrimidineethanol, alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-,(alphaR,betaS)- ; DRG-0301 ; UK-109,496 ; UNII-JFU09I87TR ; VRC ; Vfend ; Voriconazole ; (R-(R*,S*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol ; 4-Pyrimidineethanol, alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-, (R-(R*,S*))- . It is a?cyrstalline solid. |
| Biological Activity: | Triazole antifungal agent. Displays potent activity against Candida , Cryptococcus and Aspergillus species. |
| Usage: | An antifungal. An Ergosterol Biosynthesis inhibitor |
| Safety Data | |
| Hazard Symbols |
Xn: Harmful
|
 |
|
